Compare SGI & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGI | BNTX |
|---|---|---|
| Founded | 1846 | 2008 |
| Country | United States | Germany |
| Employees | 19000 | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3B | 24.2B |
| IPO Year | N/A | 2019 |
| Metric | SGI | BNTX |
|---|---|---|
| Price | $75.17 | $96.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | $97.88 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 2.7M | 787.1K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.90% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.30 | N/A |
| Revenue Next Year | $4.99 | $3.37 |
| P/E Ratio | $48.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $56.15 | $79.81 |
| 52 Week High | $98.56 | $124.00 |
| Indicator | SGI | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 45.30 |
| Support Level | $69.86 | $91.74 |
| Resistance Level | $75.69 | $113.05 |
| Average True Range (ATR) | 3.00 | 3.65 |
| MACD | -0.48 | -0.38 |
| Stochastic Oscillator | 6.33 | 8.10 |
Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses Mattress Firm, Tempur Sealy North America and Tempur Sealy International. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.